1. Home
  2. ZVRA vs ALRS Comparison

ZVRA vs ALRS Comparison

Compare ZVRA & ALRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • ALRS
  • Stock Information
  • Founded
  • ZVRA 2006
  • ALRS 1879
  • Country
  • ZVRA United States
  • ALRS United States
  • Employees
  • ZVRA N/A
  • ALRS N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • ALRS Major Banks
  • Sector
  • ZVRA Health Care
  • ALRS Finance
  • Exchange
  • ZVRA Nasdaq
  • ALRS Nasdaq
  • Market Cap
  • ZVRA 481.7M
  • ALRS 572.8M
  • IPO Year
  • ZVRA 2015
  • ALRS 2019
  • Fundamental
  • Price
  • ZVRA $11.05
  • ALRS $20.97
  • Analyst Decision
  • ZVRA Strong Buy
  • ALRS Hold
  • Analyst Count
  • ZVRA 9
  • ALRS 5
  • Target Price
  • ZVRA $23.25
  • ALRS $25.30
  • AVG Volume (30 Days)
  • ZVRA 1.2M
  • ALRS 66.5K
  • Earning Date
  • ZVRA 08-12-2025
  • ALRS 07-28-2025
  • Dividend Yield
  • ZVRA N/A
  • ALRS 4.11%
  • EPS Growth
  • ZVRA N/A
  • ALRS 350.18
  • EPS
  • ZVRA N/A
  • ALRS 1.59
  • Revenue
  • ZVRA $40,588,000.00
  • ALRS $252,130,000.00
  • Revenue This Year
  • ZVRA $303.00
  • ALRS $40.80
  • Revenue Next Year
  • ZVRA $77.66
  • ALRS $3.69
  • P/E Ratio
  • ZVRA N/A
  • ALRS $12.83
  • Revenue Growth
  • ZVRA 46.47
  • ALRS 53.68
  • 52 Week Low
  • ZVRA $6.19
  • ALRS $15.78
  • 52 Week High
  • ZVRA $13.16
  • ALRS $24.41
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 50.02
  • ALRS 42.57
  • Support Level
  • ZVRA $10.69
  • ALRS $21.35
  • Resistance Level
  • ZVRA $11.37
  • ALRS $24.33
  • Average True Range (ATR)
  • ZVRA 0.49
  • ALRS 0.71
  • MACD
  • ZVRA -0.21
  • ALRS -0.20
  • Stochastic Oscillator
  • ZVRA 12.50
  • ALRS 17.44

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About ALRS Alerus Financial Corporation

Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.

Share on Social Networks: